 WES MOORE, Governor  Ch. 394  
 
– 1 – Chapter 394  
(House Bill 1007 ) 
 
AN ACT concerning  
 
Genetic Testing – Prohibition on Disability, Life, and Long –Term Care 
Insurance   
Disability and Life Insurance – Medical Information  
(Genetic Testing Protection Act)  
 
FOR the purpose of prohibiting insurance carriers that offer life insurance , long–term care 
insurance,  or disability insurance policies or contracts from taking certain actions 
relating to coverage based on whether an applicant or a policy or contract holder has 
requested or undergone genetic testing or the results of the genetic testing;  unfairly 
discriminating against an individual by taking certain actions relating to coverage 
based on medical information;  prohibiting certain carriers from accessing sensitive 
medical information without first obtaining written consent or mandating certain 
genetic testing or full genome sequencing for a certain purpose;  and generally 
relating to genetic testing  life and disa bility insurance . 
 
BY adding to  
 Article – Insurance  
Section 27 –909.1  
 Annotated Code of Maryland  
 (2017 Replacement Volume and 2024 Supplement)  
 
 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 
That the Laws of Maryland read as follows:  
 
Article – Insurance  
 
27–909.1.  
 
 (A) (1) IN THIS SECTION THE F OLLOWING WORDS HAVE THE MEANINGS 
INDICATED . 
 
  (2) “GENE PRODUCT ” MEANS THE BIOCHEMICA L MATERIAL , EITHER  
RNA  OR PROTEIN , MADE BY A GENE . 
 
  (3) (I) “GENETIC INFORMATION ” MEANS INFORMATION : 
 
    1. DERIVED FROM A GENET IC TEST ABOUT  
CHROMOSOMES , GENES , OR GENE PRODUCTS THA T MAY DERIVE FROM AN  
INDIVIDUAL OR A FAMI LY MEMBER ; 
 
Ch. 394  2025 LAWS OF MARYLAND   
 
– 2 –     2. NOT OBTAINED FOR DIA GNOSTIC OR THERAPEUT IC 
PURPOSES ; AND  
 
    3. OBTAINED AT A TIME W HEN THE INDIVIDUAL T O 
WHOM THE INF ORMATION RELATES IS ASYMPTOMATIC FOR THE  DISEASE , 
DISORDER , ILLNESS , OR IMPAIRMENT TO WHI CH THE INFORMATION R ELATES .  
 
   (II) “GENETIC INFORMATION ” DOES NOT INCLUDE : 
 
    1. ROUTINE PHYSICAL MEA SUREMENTS ; 
 
    2. CHEMICAL , BLOOD , AND URINE ANALYSES T HAT ARE 
WIDELY ACCEPTED AND IN USE IN CLINICAL P RACTICE ;  
 
    3. TESTS FOR USE OF DRU GS;  
 
    4. TESTS FOR THE PRESEN CE OF THE HUMAN  
IMMUNODEFICIENCY VIR US; OR 
 
    5. FAMILY MEDICAL HISTO RY, EXCEPT FOR FAMILY  
GENETICS AS THEY REL ATE TO A GENETIC TES T DESCRIBED IN SUBPARA GRAPH (I)1 
OF THIS PARAGRAPH . 
 
  (4) “GENETIC SERVICES ” MEANS HEALTH SERVICE S THAT ARE  
PROVIDED TO OBTAIN , ASSESS , OR INTERPRET GENETIC  INFORMATION OR THE  
RESULTS OF GENETIC T ESTS .  
 
  (5) (2) “GENETIC TEST ” MEANS AN ANALYSIS OF  HUMAN DNA,  
RNA,  CHROMOSOMES , PROTEINS , OR METABOLITES THAT DETECTS GENOTYPES , 
MUTATIONS , OR CHROMOSOMAL CHANG ES. 
 
  (6) (3) “INSURANCE CARRIER ” MEANS A COMPANY AUTH ORIZED 
TO SELL INSURANCE PO LICIES IN THE STATE . 
 
 (B) (1) THIS SECTION APPLIES ONLY TO LIFE INSURANCE , LONG–TERM  
CARE INSURANCE , AND DISABILITY INSUR ANCE POLICIES OR CON TRACTS . 
 
  (2) THIS SECTION DOES NOT  PROHIBIT AN INSURANC E CARRIER THAT 
OFFERS , ISSUES , OR DELIVERS A LIFE I NSURANCE , LONG–TERM CARE INSURANCE , 
OR DISABILITY INSURA NCE POLICY OR C ONTRACT IN THE STATE FROM : 
 
   (I) ACCESSING AN APPLICA NT’S MEDICAL RECORD AS PART OF 
THE APPLICATION PROC ESS; OR 
 
 WES MOORE, Governor  Ch. 394  
 
– 3 –    (II) CONSIDERING A MEDICA L DIAGNOSIS INCLUDED  IN AN 
INDIVIDUAL ’S MEDICAL RECORD , EVEN IF THE DIAGNOSI S WAS BASED ON THE 
RESULTS OF A GENET IC TEST . 
 
 (C) (1) AN EXCEPT AS PROVIDED IN  PARAGRAPH (2) OF THIS 
SUBSECTION AND SUBJE CT TO PARAGRAPH (3) OF THIS SUBSECTION , AN 
INSURANCE CARRIER TH AT OFFERS , ISSUES , OR DELIVERS A LIFE I NSURANCE , 
LONG–TERM CARE INSURANCE , OR DISABILITY INSURA NCE POLICY O R CONTRACT IN 
THE STATE MAY NOT : UNFAIRLY DISCRIMINAT E AGAINST AN INDIVID UAL BY 
CONDITIONING INSURAN CE RATES , THE PROVISION OR REN EWAL OF INSURANCE 
COVERAGE , OR OTHER CONDITIONS OF INSURANCE BASED O N MEDICAL 
INFORMATION , INCLUDING THE RESULT S OF A GENETIC TEST FOR WHICH THERE  IS 
NOT A RELATIONSHIP B ETWEEN THE MEDICAL I NFORMATION AND THE C OST OF THE 
INSURANCE RISK THAT THE INSURER WOULD AS SUME BY INSURING THE  APPLICANT .  
 
  (2) IN DEMONSTRATING THE RELATIONSHIP DESCRIB ED IN 
PARAGRAPH (1) OF THIS SUBSECTION , THE INSURER MAY RELY  ON ACTUARIALLY 
SOUND PRINCIPLES OR ACTUAL OR REASONABLY  ANTICIPATED EXPERIEN CE. 
 
  (3) AN INSURANCE CARRIER THAT OFFERS , ISSUES , OR DELIVERS A 
LIFE INSURANCE OR DI SABILITY INSURANCE P OLICY OR CONTRACT IN  THE STATE 
MAY NOT : 
 
   (I) ACCESS SENSITIVE MED ICAL INFORMATION , INCLUDING 
THE GENETIC DATA OF AN INDIVIDUAL , WITHOUT FIRST OBTAIN ING THE 
INDIVIDUAL ’S SIGNED , WRITTEN CONSENT ; OR 
 
   (II) MANDATE EXISTING OR NEW GENETIC TESTING OR FULL 
GENOME SEQUENCING AS  A PREREQUISITE FOR L IFE IN SURANCE OR DISABILIT Y 
INSURANCE ELIGIBILIT Y OR COVERAGE .  
 
   (I) DENY OR LIMIT COVERA GE BASED ON WHETHER AN 
APPLICANT OR A POLIC Y OR CONTRACT HOLDER  HAS UNDERGONE A GENE TIC TEST ; 
 
   (II) PROHIBIT , AS A CONDITION OF CO NTINUING COVERAGE , A 
POLICY OR CONTRA CT HOLDER FROM UNDER GOING A GENETIC TEST ; OR 
 
   (III) USE A GENETIC TEST , THE RESULTS OF A GEN ETIC TEST , 
GENETIC INFORMATION , OR A REQUEST FOR GEN ETIC SERVICES TO REJ ECT, DENY , 
LIMIT , CANCEL , REFUSE TO RENEW , INCREASE THE RATES O F, AFFECT THE TERMS  
OR CON DITIONS OF , OR OTHERWISE AFFECT A LIFE INSURANCE , LONG–TERM CARE  
INSURANCE , OR DISABILITY INSURA NCE POLICY OR CONTRA CT. 
 
Ch. 394  2025 LAWS OF MARYLAND   
 
– 4 –   (2) (4) THE INSURANCE CARRIER , APPLICANT , OR POLICY OR 
CONTRACT HOLDER MAY NOT CHANGE , WAIVE , DISCHARGE , OR TERMINATE  THE 
PROVISIONS OF PARAGR APH (1) (3)( II) OF THIS SUBSECTION U NDER ANY 
CIRCUMSTANCES . 
 
 (D) THE COMMISSIONER MAY ISSU E AN ORDER UNDER §§ 4–113 AND 4–114 
OF THIS ARTICLE OR §§ 27–501 AND 27–505 OF THIS TITLE IF THE  COMMISSIONER 
FINDS A VIOLATION OF  THIS SECT ION.  
 
 SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect 
October 1, 2025.  
 
Approved by the Governor, May 6, 2025.  